Evaluation of Tolerance and Acceptability of a Coated Condom

Inclusion criteria: * Healthy sexually active mutually monogamous heterosexual couples. * Subjects at least 18 years of age * Subjects who are willing and able to take part, attend all required visits, able to understand the information given to them and give written consent * Couples who are be experienced latex condom users as defined by repeated use without significant problems. * Couples must agree to use the condoms provided plus be using one other acceptable form of non barrier contraception (i.e. sterilisation/vasectomy, intra-uterine device (IUD) or intra-uterine system (IUS), hormonal contraception) unless female partner is post-menopausal (i.e. over 50 and, prior to screening, amenorrhea for at least 12 months after cessation of exogenous hormone treatment) in which case no second form of contraception is required. * No signs of abnormalities in the medical history that the investigator would consider as clinically relevant. * No clinically relevant findings in physical assessments * Subject not aware of any reason why they will not be able to engage in 1 act of vaginal intercourse per Condon Use Period. Exclusion Criteria: * Presence or history of allergy or sensitivity to topical vaginal products Latex, Xanthan Gum or any other Investigation products * Pre-existing skin or systemic allergic reaction or severe eczema * Previous history of frequent problems associated with the use of condoms * Currently active or a history of recurrent STI's including HIV infection in one or either partner. * Participation in a clinical trial in the previous month which could, in the opinion of the investigator, affect the outcome of the Investigation. * Intentions to continue use of concurrent vaginal lubricants or treatments for the duration of the Investigation. * Either partner with genital piercing * Female partners who are pregnant or breast feeding * Female partners seeking to become pregnant in the duration of the Investigation * Female partner who has been diagnosed with or treated for a vaginal complaint in the previous 3 months which in the Investigators opinion indicated the partner is unsuitable for the Investigation * Female partner suffering from known vaginal dryness * Female partner using medication which would affect vaginal mucosal secretion, such as Chlorpheniramine. * Male partners using medication that would affect ability to obtain and maintain an erection through to normal ejaculation * Male partners with abnormal penile anatomy that would affect ability to keep condom in place during intercourse * Males partner with diagnosis of penile skin condition within previous 3 months (e.g. conditions associated with balanoposthitis: penile psoriasis; lichen sclerosis; eczema) as confirmed by subject and by genital examination. * Intentions to continue to use antihistamines, anti inflammatory drugs, or pain killers for the duration of the Investigation * Suffering from any condition which could, in the opinion of the Investigator, affect the outcome of the Investigation